Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Health news
  • NMC News
  • NMC invites comments...

NMC invites comments from medical colleges on draft prevention of cruelty to animals rules 2026 to regulate animal experiments

Written By : Barsha Misra Published On 2026-11-17T09:30:52+05:30  |  Updated On 17 Nov 2026 4:45 PM IST
nmc seeks comments
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The National Medical Commission (NMC) has invited comments, objections, and suggestions from medical colleges on the Draft Prevention of Cruelty to Animals (Control and Supervision of Experiment, Breeding and Trading of Laboratory Animals) Rules, 2026.

The Draft was notified by the Gazette Notification No. G.S.R. 864(E) dated 30.09.2026 and consequently, the Government of India, Ministry of Fisheries, Animal Husbandry and Dairying, Department of Animal Husbandry and Dairying, through the Committee for Control and Supervision of Experiments on Animals (CCSEA) forwarded the same to NMC.

Accordingly, the Apex Medical Commission has sought comments in this regard from all medical colleges and medical institutes under the purview of NMC within 30 days.

"All Medical Colleges and Medical Institutions under the purview of the National Medical Commission (NMC) are requested to examine the aforesaid draft Rules carefully and furnish their comments, suggestions and objections, if any, directly to the Member Secretary (CCSEA), Office of CCSEA, Near State Bank of India, Delhi Milk Scheme Complex, Shadipur, Delhi – 110 008, or by email, within 30 days from the date of publication of this Public Notice. A copy of the submission may also be endorsed to Prof. (Dr.) Mahendra Kumar Pant, Sr. Advisor, National Medical Commission by email," a Public Notice, issued by NMC Secretary Dr. Raghav Langer on 16.11.2026, stated.

NMC said that the draft Rules aim to regulate and supervise the use of animals for scientific and educational purposes, including their breeding, housing, care and use in experiments. They also provide for the registration of establishments, approval of experiments and constitution of Institutional Animal Ethics Committees (IAECs), among other provisions.

Draft Prevention of Cruelty to Animals (Control and Supervision of Experiment, Breeding and Trading of Laboratory Animals) Rules, 2026:

The Committee for Control and Supervision of Experiments on Animals under the Department of Animal Husbandry and Dairying, operating under the Ministry of Fisheries, Animal Husbandry and Dairying, released the Draft on 30th September, 2026.

These rules lay down the guidelines for the replacement and reduction of the use of animals in experiments and the refinement of the breeding, accommodation, care, and use of animals in experiments, the origin, breeding, marking, care and accommodation and euthanasia of animals, the operation of breeders, traders and users, and the evaluation and authorisation of projects involving the use of animals in experiments.

Application of these rules:

Regarding the application of the rules, the draft states the following:

(i) These Rules shall apply where animals are used or intended to be used in experiments or bred specifically so that their organs or tissues may be used for scientific purposes.

(ii) These Rules shall apply until the animals have been euthanized, rehabilitated to a suitable habitat or husbandry system upon completion of experimentation.

(iii) The elimination of pain, suffering, distress or lasting harm by the successful use of anaesthesia, analgesia or other methods shall not exclude the use of an animal in experiments from the scope of these Rules.

(iv) These Rules shall apply to live non-human vertebrate animals, including independent feeding larval forms of fishes, embryonated eggs and foetal forms of mammals as from the last third stage of their normal development;

(v) These Rules shall apply to animals used in experiments, which are at an earlier stage of development than that referred to sub-rule 8, if the animal is to be allowed to live beyond that stage of development and, as a result of the experiments performed, is likely to experience pain, suffering, distress or lasting harm after it has reached that stage of development.

These Rules shall not apply to the following:

(a) non-experimental agricultural practices;

(b) non-experimental clinical veterinary practices;

(c) veterinary clinical field trial required for the marketing authorization of a legally approved veterinary medicinal product except test batch and quality control trial for batch manufacturing;

(d) practices undertaken for the purposes of recognised animal husbandry;

(e) practices undertaken for the primary purpose of identification of an animal;

(f) practices not likely to cause pain, suffering, distress or lasting harm equivalent to, or higher than, that caused by the introduction of a needle in accordance with good veterinary practice.

The Draft rules define the purposes of experiments, the category of animal on which the experiment shall be prohibited, experiments on non-human primates, classification of the severity of experiments, requirements for breeders, traders and users, Registration of establishments conducting experiments on animals or housing, breeding and trading of animals for experimental purposes, processing of applications, Permission of the Committee required for conducting experiments, Competency of personnel, Specific requirements for personnel, and designated veterinarian.

It also lays down the rules regarding the Procedures for experiments, Composition of the Institutional Animal Ethics Committee (IAEC), Conduct of business of IAEC, record-keeping of experiments conducted, Stocking of animals for experiments, breeding, housing and trading, reporting by establishment, Transfer and acquisition of animals for experiments, Contract research on animals, renewal, Periodical inspection of the establishment, Power to suspend or revoke registration, and Appeal.

Replacement, Reduction and Refinement (3Rs). -

For the purpose of implementation of principle of replacement, reduction and refinement (3Rs), the registered establishments carrying out the experiment shall ensure.-

(1) that, wherever possible, a scientifically satisfactory method or testing strategy, not entailing the use of live animals, shall be used instead of an experiment;

(2) that the number of animals used in projects is reduced to a minimum necessary to obtain scientifically valid and statistically reliable results without compromising the objectives of the project;

(3) that refinement of breeding, accommodation and care, and of methods used in experiments, eliminating or reducing to the minimum any possible pain, suffering, distress or lasting harm to the animals, adequate environmental enrichment, adoption of best veterinary practices and the use of validated humane endpoints.

Purposes of Experiments.

Experiments may be carried out for the following purposes only:

(1) basic research aimed at the advancement of knowledge, including fundamental research in biological, biomedical, behavioural or veterinary sciences.

(2) translational or applied research with one or more of the following aims:

(a) the avoidance, prevention, diagnosis or treatment of disease, ill-health or other pathological conditions or their effects on human beings, animals or plants;

(b) the assessment, detection, regulation or modification of physiological conditions in human beings, animals or plants; or

(c) the welfare of animals and the improvement of the production conditions for animals reared for agricultural purposes;

(3) for any of the aims in sub-rule (2) in the development, manufacture or testing of the quality, effectiveness and safety of drugs, food and feed stuffs and other substances or products;

(4) protection of the natural environment in the interests of the health or welfare of human beings or animals;

(5) research aimed at preservation of the species;

(6) higher education, or professional training for the acquisition, maintenance or improvement of vocational skills;

(7) forensic investigations in accordance with the legal requirement. (8) Process of bleeding/blood products

Category of animals on which the experiment shall be prohibited.-

(1) Specimens of those animals protected under Wildlife (Protection) Amendment Act, 2022, shall not be used in experiments, with the exceptions of those experiments meeting the following conditions:

(a) the experiment has one of the purposes referred to in clause (a) of sub-rule (2), sub-rule (3) or sub-rule ( 5) of Rule 4 of these Rules; and

(b) there is scientific justification to the effect that the purpose of the experiment cannot be achieved using species other than the endangered species;

(c) sub-rule (1) shall not apply to any species of non-human primates;

(d) permission of competent authorities as per applicable law has been granted.

(2) Animals taken from the wild-

(a) Animals taken from the wild shall not be used in experiments unless the Competent authority of the relevant department grants exemptions based on scientific justification to the effect that the purpose of the experiments cannot be achieved by the use of an animal which has been bred for use in experiments;

(b) The capture of animals in the wild shall be carried out only by authorised competent person using methods which do not cause the animals avoidable pain, suffering, distress or lasting harm;

(c) Any animal found during or after capture, injured or in poor health shall be examined by a veterinarian or any other authorized person under the supervision of a veterinarian, and action shall be taken to minimise the suffering of the animal. Competent authorities may grant exemptions from the requirement of taking action to minimise the suffering of the animal if there is scientific justification;

(d) The Committee shall review the use of sourcing non- human primates from selfsustaining colonies as defined in the guidelines of CCSEA.

(3) Stray and feral animals of domestic species.-

Stray and feral animals of domestic species shall not be used in experiments provided; the competent authorities may grant exemptions subject to the following conditions.-

(a) there is an essential need for studies concerning the health and welfare of the animals or serious threats to the environment or to human or animal health; and

(b) there is scientific justification to the effect that the purpose of the experiment can be achieved only by using stray or a feral animal.

Experiment on non-human primates. -

Subject to Rule 5, specimens of non-human primates shall not be used in experiments, except for those experiments meeting the following conditions.-

(1) the experiment has one of the purposes referred to in-

(a) clause (a) of sub-rule (2) or sub-rule (3) of Rule 4 of these Rules is undertaken with a view to the avoidance, prevention, diagnosis or treatment of debilitating or potentially life- threatening clinical conditions in human beings; or

(b) sub-rule (1) or (5) of Rule 4; and

(c) there is scientific justification to the effect that the purpose of the experiment cannot be achieved by the use of species other than non- human primates.

Note: A debilitating clinical condition for the purposes of these Rules means a reduction in a person’s normal physical or psychological ability to function.

(2) Specimens of non-human primates listed in the Wildlife (Protection) Amendment Act, 2022, shall not be used in experiments.

Classification of severity of experiments. -

(1) The establishment shall follow the severity of experiment, classified as ‘non-recovery’, ‘mild’, ‘moderate’, or ‘severe’ on a case-by-case basis as set out in Annexure -I

(2) The establishments shall ensure that an experiment is not performed if it involves severe pain, suffering or distress that is likely to be long period and cannot be ameliorated.

Requirements for breeders, traders and users.-

(1) No establishment shall carry out the business or house animals for breeding or trading of animals for the purpose of experiments unless it is registered with the CCSEA;

(2) Every breeder, trader or establishment shall apply for registration through existing online portal developed by CCSEA for carrying out the business of:

(i) breeding animals for the purpose of experiments

(ii) trading of animals for the purpose of experiments,

(iii) breeding and trading animals for the purpose of experiment

(3) The Traders shall ensure that animals bred, procured and housed by the establishment are traded only to the CCSEA registered establishments on approval of the IAEC of the receiving establishment or Committee, as the case may be.

(4) The breeders and traders shall submit quarterly report to IAEC and annual report for each financial year in the prescribed form at schedule VII on or before 31st March of each year to the Committee.

Registration of establishments conducting experiments on animals or housing, breeding and trading of animals for experimental purposes. –

(1) No establishment shall perform any experiment on animals or house, breed and/or trade any animal for experiments unless it is registered with the CCSEA as per the provisions under these rule(s).

(2) Every establishment performing experiments on animal(s) or housing, breeding and trading of animals for experimental purposes shall apply for registration, in prescribed format at schedule I through online portal of CCSEA to the Member Secretary with specified fees.

Processing of applications.-

(1) All the applications submitted as per Rule 9 in the office of CCSEA shall be processed as under:

(a) The Member-Secretary shall verify the fact by himself or depute nominee of CCSEA or representative of CCSEA for verification of facts mentioned in the application for registration;

(b) After receiving satisfactory report and information in Schedule II, the Member Secretary shall register such establishment;

(c) An establishment shall be duty-bound to comply with the conditions of registration, or any conditions prescribed by the Committee;

(d) The Committee shall take a decision on the registration within specified period as mentioned in the Administrative (Committee for Control and Supervision of Experiments on Animals) Rules, 2023;

(e) The Committee shall communicate the modification of facilities, if needed, before registration and taking the final decision on registration;

(f) Each establishment registered under Committee shall bear a unique registration code and number for each purpose;

(g) The registration certificate issued to the establishment maintaining Animal House Facilities including the IAEC shall remain valid for three years unless its terminated or withdrawn by the establishment or Committee as the case may be.

Permission of the Committee required for conducting experiments. –

(1) Every establishment registered with CCSEA shall obtain permission either from the Committee or the Institutional Animals Ethics Committee before conducting experiment, as the case may be;

(2) Every establishment, conducting severe and non-recovery experiments as defined under Rule 7 on animals above the category of rodent and lagomorph, shall apply to CCSEA by providing details in Schedule III through online portal after recommendation of IAEC. Decision on such applications shall be taken by the Committee within thirty working days.

(3) Every establishment conducting experiments which have been defined as mild and moderate including such experiments on all animals,shallsubmit their application as per Schedule III to the Member Secretary of IAEC for decision on the experiment. Such experiment shall not be referred to the Committee;

(4) In case of approvals on mild and moderate experiments on animals above lagomorphs, the IAEC shall ensure timely and scheduled reporting to the Committee, at a minimum of three stages namely; study initiation, interim progress, and study completion—covering progress, deviations (if any), and compliance with the principles of the 3Rs (Replacement, Reduction, and Refinement), as specified;

(5) Reports submitted by the IAEC shall be placed before the committee at the next available meeting of the Committee;

(6) The Member Secretary of the Committee or the IAEC, shall cause the application for permission to be brought before the Committee or IAEC as the case may be, and the Committee or IAEC after scrutiny of the application, if satisfied, may grant permission to the establishment stating the name of the species and the number of animalsthat can be acquired or used for carrying out the specific experiment;

(7) The Committee or IAEC while granting permission for conducting experiments on animals, may prescribe conditions as may deem fit to ensure that animals are not subjected to unnecessary pain or suffering before, during or after the performance of experiments on them;

(8) The Committee may seek such information, as it may require but limited to the welfare of the animals, on completion of experiments for which permission was granted.

(9) The principal investigator carrying out experiments shall maintain the information as per Schedule IV which shall be submitted to Member Secretary of the IAEC in the first meeting fixed immediately after completion of experiment;

(10) The animal(s) to be used for experimentation shall mandatorily be certified by the Veterinarian of the IAEC to the effect that the experiments are mild, severe, moderate or noninvasive in nature and the animal is fit for the desired experiment;

(11) The IAEC may grant approval for class of experiment of repetitive or curriculum-based teaching for a period not exceeding five years subject to such conditions and periodic reviews as may be specified by the committee; Provided that fresh approval shall be required where there is any material change in species, number of animals, severity of experiment or experimental procedure.

Competency of personnel.-

(1) Person in-charge or Head of the establishments shall ensure that each breeder, trader and user has sufficient staff on site.

(2) The staff should be adequately educated and trained before they perform any of the following functions

(a) carrying out experiments on animals;

(b) designing experiments and projects;

(c) taking care of animals; or

(d) euthanasia of animals.

Note: The establishment shall maintain proper documents in support of education, experience, registration of veterinarian and training.

(3) Persons carrying out the functions referred to in clause (b) shall have received instruction in a scientific discipline relevant to the work being undertaken and shall have species-specific knowledge.

(4) Staff carrying out functions referred to in clause (a), (c) or (d) shall be supervised in the performance of their tasks until they have demonstrated the requisite competence.

(5) Establishment shall ensure, through authorisation or by other means, that the requirements laid down in this paragraph are fulfilled.

(6) Establishment shall publish minimum requirements with regard to education and training and the requirements for obtaining, maintaining and demonstrating requisite competence for the functions set out in paragraph 2.

Specific requirements for personnel.-

(1) the Person in-charge or Head of the establishment shall ensure that each breeder, trader and user has one or several persons on site who shall:

(a) be responsible for overseeing the welfare and care of the animals in the establishment;

(b) ensure that the staff dealing with animals have access to information specific to the species housed in the establishment;

(c) be responsible for ensuring that the staff are adequately educated, competent and continuously trained and that they are supervised until they have demonstrated the requisite competence.

(2) Person in charge or Head of establishments shall ensure that personnel shall:

(a) ensure that any unnecessary pain, suffering, distress or lasting harm that is being inflicted on an animal in the course of an experiment is stopped; and

(b) ensure that the projects are carried out in accordance with the project authorisation or, in accordance with the application sent to the IAEC or CCSEA or any decision taken by the IAEC or CCSEA, and ensure that in the event of non-compliance, the appropriate measures to rectify it are taken and recorded.

Designated veterinarian. -

(1) The person in charge of establishments shall ensure that each breeder and user has appointed a veterinarian to advise and monitor the well-being and treatment of animals.

(2) All experiments shall be performed under the supervision of a veterinarian.

Procedures for experiments. -

(1) The CCSEA shall issue detailed order or guidelines for experiments, or breeding or trading of an animal from time to time to minimize their pain and sufferings before, during and after the experimentation including rehabilitation and reuse;

(2) The CCSEA shall also prescribe the specific standards for welfare of animals to be followed by the establishment for housing animals during and after the experiment on animals which shall be binding on the establishments;

(3) The establishment shall not perform any experiment or use any chemical or agents which are banned by any authority and not required for testing.

(4) As far as possible, death as the endpoint of an experiment shall be avoided and replaced by early and humane endpoints. If death as the endpoint is unavoidable, the experiment shall be designed so as to:

(a) minimize the number of deaths of animals as much as possible; and

(b) minimize as much as possible, the duration and intensity of suffering to the animal to ensure a painless death;

(c) every establishment must maintain a dedicated euthanasia registry detailing the date, species, exact method/chemical agent utilized, dosage, reason for termination, and the cosignatures of both the executing investigator and the Designated Veterinarian.

Composition of Institutional Animals Ethics Committee (IAEC). –

(1) Every establishment shall mandatorily constitute nine members for control and supervision of experiment, breeding, housing and trading which will be valid for three years.

(2) The constitution of IAEC shall include a biologist, two scientists from different biological disciplines, a veterinarian involved in the care of animals, and the scientist in charge of animal facility from the respective establishments. The CCSEA shall nominate a main nominee, link nominee, scientist from outside the institute and socially aware nominee in the IAEC;

(3) The nominees of CCSEA shall be selected from the list of nominees selected by CCSEA after due process;

(4) The establishment shall nominate Chairperson and Member Secretary from amongst the internal members of IAEC except the nominated members by the CCSEA;

(5) In addition to the above IAEC members, a specialist, in the relevant field, shall be coopted while reviewing special projects using hazardous agents such as radio-active substances and deadly micro-organisms. Though, the co-opted member shall not be part of the decision making of the IAEC, their advice to be taken seriously before making any decision by IAEC.

(6) IAEC shall not be required for Traders involved in supply of animals from breeders to the users without housing of animals.

Conduct of business of IAEC.-

(1) The Chairperson of IAEC shall convene minimum of two meetings of IAEC in a calendar year, requiring at least one meeting to be held in each half of a calendar year;

(2) The quorum of the IAEC meeting shall be of six members wherein mandatory presence of Main Nominee and Socially Aware Nominee is must;

(3) Link Nominee can attend any IAEC meeting in case Main Nominee conveys his/ her unavailability in writing to the Chairperson of IAEC.

(4) Any decision taken in the meetings of IAEC without quorum shall be considered invalid;

(5) The Chairperson is responsible for submission of minutes of the meeting of IAEC through the web portal within fifteen days from the date of the IAEC meeting as per Schedule V.

Record keeping of experiments conducted. –

(1) Every establishment shall maintain the records of animals utilized for Experiments in the Schedule IV, animals bred or acquired for experimentation in the Schedule VI and record of animal sold or transferred in the Schedule VII.

(2) All such records shall be made available for inspection to the Committee or any other officer authorized by the Committee from time to time.

Stocking of animals for experiments, breeding, housing and trading. -

(1) The Committee shall prescribe technical parameters for stocking of animals including technical specifications for their housing but not limited to the following broad guidelines.-

(a) Animal houses shall be located in a quiet atmosphere undisturbed by traffic, and the premises kept tidy, hygienic and the animals protected from drought and extremes of weather.

(b) Animal cages for small animals and stables for large animals shall be made in such a manner that provides comfort to animals and not overcrowded.

(c) Where standards have been laid down by the Committee, the cages, the stable, as the case may be, shall conform to those standards.

(d) Detailed specifications for housing, feeding and maintenance of various species to be used in animal experimentation as notified by the Committee, shall be adhered by the registered establishment.

(e) Each establishment shall provide species specific environmental enrichment and ethological needs.

(f) Establishment housing large animals must maintain species-specific exercise and rehabilitation area as the case may be.

(2) Registered establishments housing animals exposed to Risk Group III or IV agents must maintain certified directional airflow and negative pressure integrity, subject to mandatory digital logging and annual verification by a specialized biosecurity engineer.

Reporting by establishment.-

The breeder-trader shall submit information pertaining to trading of animals in the prescribed format as mentioned in the Schedule VII annually before 31st March of every year; or any other information sought by the Committee from time to time.

Transfer and acquisition of animals for experiment. –

(1) Any registered breeder, user or establishment under these rules shall transfer or sale or acquire any animal from the CCSEA registered breeder, establishment or trader only;

(2) In the event of non-availability of a particular kind of livestock and farm animals (above level of Lagomorpha), fishes and birds, from the registered breeders or traders, they may be procured from non-registered establishments or open market with prior approval of IAEC and maintenance of documents provided such animals undergo a mandatory veterinarian-certified quarantine and stabilization period as prescribed by CCSEA guidelines prior to experimentation.

(3) Animals that are not available in the country shall be permitted for sourcing from outside the country as per the provisions of the extant Import-Export policies/guidelines.

Contract research on animals. –

Any research institution or agency not defined under the rules may also outsource research activities involving animals to an establishment duly registered under CCSEA.

Renewal. -

(1) Every establishment registered with CCSEA is required to be renewed after every three years along with the reconstruction of IAEC.

(2) While considering the renewal, the CCSEA shall consider the minutes of IAEC meetings submitted by the establishment regularly for last three years along with the Annual Inspection Reports of the Animal House Facility by the nominee in the Schedule VIII vis-à-vis Annual statement of large animals use (as the case may be) submitted in Schedule IX for last three years.

Periodic inspection of the establishment.-

(1) It is binding on the main nominee and socially aware nominee to carry out periodical inspections not less than two times in a years, apart from the meeting, to oversee the animal house with regard to their fulfilment of the CCSEA guidelines, welfare of animals housed in the establishment;

(2) The main nominee shall submit such inspection report as per Schedule VIII format annexed to these Rules;

(3) Any violations of the CCSEA rules, guidelines and prescribed standards observed by the main nominee and socially aware nominee shall be reflected in the Minutes of the IAEC meeting and also reported to the CCSEA;

(4) CCSEA shall also depute the inspection team to verify the compliance by the establishment, with prior intimation and such report shall be submitted as per Schedule II format.

Power to suspend or revoke registration. –

(1) based on the periodical inspection report received from the main nominee or socially aware nominee in accordance with Rule 24 or any complaints made by any person, organization which have been verified through inspections, if there is a reason to believe that the provisions of the act or rules have been contravened, the committee shall.-

(a) issue a deficiency notice specifying the nature of non-compliance and requiring corrective action within 15 days of issuance of notice;

(b) where the establishment fails to comply with the deficiency noticed within 15 days or where repeated instances of violation occurred within six months, the Committee may, and after giving the establishment a reasonable opportunity of being heard, suspend or revoke the registration.

(b) Notwithstanding anything contained in sub-rule (1) where the committee is satisfied that the non-compliance is limited to a specific project or protocol or unit or facility, it may restrict suspension or revocation to such project or protocol or unit or facility of the said establishment and permit the continued operation of unaffected and compliant activities subject to such conditions and enhance monitoring as it may deem fit.

(c) Nothing in Rule 25 shall prevent the Committee from ordering immediate suspension or revocation, in whole or in part, where it is satisfied that there exists an imminent risk to the life, health, or welfare of the animals.

Appeal. –

(1) Establishment aggrieved with any decision of the committee may, if so desire, file an appeal to the Secretary of the Administrative Ministry of CCSEA, within thirty days of receipt of the decision;

(2) The Secretary of the Administrative Ministry on receipt of the grievance, if so desire, shall after giving notice to the aggrieved establishment, hear the grievance, either by himself or herself or through a Committee and decide on the appeal to reject or allow citing the reasons in writing;

(3) The decision of the Secretary of Administrative Ministry shall be treated as final decision regarding the grievance.

To view the NMC notice and the Draft, click on the link below:

https://medicaldialogues.in/pdf_upload/2026/11/17/nmc-animal-cruelty-draft-483897.pdf

Also Read: PETA Slams Hyderabad Pharma Lab, Seeks CCSEA Action to Rescue 1,200 Beagles, Monkeys

national medical commissionNMCPrevention of Cruelty to Animals Rules 2026medical collegesanimal experimentation

Medical Survey

Barsha Misra
Barsha Misra

M.A in English Barsha completed her Master's in English from the University of Burdwan, West Bengal in 2018. Having a knack for Journalism she joined Medical Dialogues back in 2020. She mainly covers news about medico legal cases, NMC/DCI updates, medical education issues including the latest updates about medical and dental colleges in India. She can be contacted at editorial@medicaldialogues.in.

Print Article
Show Full Article
Next Story
Recommended For You
NO DATA FOUND

Editorial

Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians

Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians

Jural Exploitation of Healthcare Professionals and Institutions in the PM-RAHAT Scheme - Dr Rajeev Joshi

Jural Exploitation of Healthcare Professionals and Institutions in the PM-RAHAT Scheme - Dr Rajeev...

Metformin - Eight Points on a Metabolic Anchor in T2D: World Diabetes Day Special

Metformin - Eight Points on a Metabolic Anchor in T2D: World Diabetes Day Special

Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination - Dr. Makarand Damle

Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination...

Effect of Saroglitazar in MASLD: Latest Indian 2026 Study

Effect of Saroglitazar in MASLD: Latest Indian 2026 Study

View All

Journal Club Today

Heart Attacks at 30? Why Young Indians are at Risk | Dr Praveen Singh

Heart Attacks at 30? Why Young Indians are at Risk | Dr Praveen Singh

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok